Rocket Lab
RKLB
$75.67
+1.14%
Rocket Lab Corporation is a vertically integrated space company providing launch services, spacecraft manufacturing, and space systems solutions for civil, defense, and commercial markets. It operates two segments: Launch Services, featuring the Electron and upcoming Neutron launch vehicles, and Space Systems, including the Photon satellite platform and related components. As a leading player in the small satellite launch niche, Rocket Lab differentiates itself through frequent, dedicated launch capabilities and an expanding space systems portfolio, positioning it as a key competitor to larger incumbents like SpaceX. The current investor narrative centers on the transformative acquisition of Iridium, which is expected to drive significant revenue growth and a path to profitability by 2027, while also introducing integration risks and a substantial debt burden that has recently weighed on the stock.…
RKLB
Rocket Lab
$75.67
Related headlines
RKLB 12-Month Price Forecast
Wall Street consensus
Most Wall Street analysts maintain a constructive view on Rocket Lab's 12-month outlook, with a consensus price target around $111.31 and implied upside of +47.1% versus the current price.
Average Target
$111.31
0 analysts
Implied Upside
+47.1%
vs. current price
Analyst Count
—
covering this stock
Price Range
$64 - $150
Analyst target range
The target price range spans from a low of $77.00 to a high of $150.00, indicating a wide dispersion of 95% between the low and high, reflecting significant uncertainty about the company's future. The high target of $150.00 assumes successful integration of Iridium, continued revenue growth, and a path to profitability, potentially justifying a higher multiple. The low target of $77.00 likely prices in integration risks, potential delays in Neutron, or competitive pressures, but still implies a 18.6% upside from the current price. Recent institutional actions show a mix of reaffirmations and upgrades, with no downgrades, suggesting that analysts remain confident despite the recent stock decline. However, the wide range and the stock's 58% drop from its high highlight the market's skepticism versus Wall Street's optimism, and investors should weigh the potential for high returns against the execution risks.
Bulls vs Bears: RKLB Investment Factors
Rocket Lab presents a classic high-growth, high-risk investment. The bull case is anchored on explosive revenue growth (63.5% YoY), a record backlog, and the transformative Iridium acquisition that could lead to profitability by 2027. However, the bear case is equally compelling: a stratospheric valuation (P/S 61.5x), persistent losses, and a 58% drawdown from highs indicate the market is pricing in perfection. Currently, the bearish evidence is stronger given the valuation and execution risks, but the stock's potential for massive upside if integration succeeds cannot be ignored. The central tension is whether Rocket Lab can execute on its growth and profitability targets without diluting shareholders or facing operational setbacks—this resolution will determine the stock's trajectory.
Bullish
- Revenue Growth Accelerating at 63.5% YoY: Q1 2026 revenue reached $200.3M, up 63.5% year-over-year, with sequential growth from $179.7M in Q4 2025 and $155.1M in Q3 2025. This accelerating trajectory is driven by both Launch Services and Space Systems, with product revenue of $127.5M and service revenue of $72.9M.
- Record Backlog and Government Contracts: The $266M U.S. Space Force contract is the largest in company history, boosting backlog visibility. This, combined with the Iridium acquisition, is expected to drive revenue to an estimated $2.64B by 2027, supporting a path to profitability.
- Improving Profitability Metrics: Net loss margin improved to -22.5% in Q1 2026 from -29.5% in Q4 2025, and gross margin expanded to 38.2% from 37.9% sequentially. The company is making tangible progress toward its goal of profitability by 2027, with analysts projecting EPS of $0.92.
- Analyst Consensus is Buy with High Targets: With 15 analysts, the consensus is 'Buy' (mean rating 1.53) and the average target price is $114.47, implying 76% upside from the current price of $64.95. The high target of $150 suggests even greater potential if execution succeeds.
Bearish
- Extreme Valuation with P/S of 61.5x: The trailing P/S ratio of 61.5x is 25x the aerospace & defense industry average of 2.5x. Even the forward P/S of 14.0x (based on $2.64B revenue) implies the market is pricing in massive growth, leaving no room for error.
- Persistent Unprofitability and Negative Cash Flow: The company reported a net loss of $45.0M in Q1 2026 and negative free cash flow of -$316.3M TTM. While losses are narrowing, the company still burns significant cash, and profitability is not expected until 2027.
- High Debt from Iridium Acquisition: The Iridium acquisition added substantial debt, with debt-to-equity now at 0.147. While manageable, the integration risk and interest burden could strain finances if revenue growth stalls or integration costs overrun.
- Stock Down 58% from High, Underperforming Market: RKLB has fallen 58% from its 52-week high of $151.00, and over the past month it dropped 35.1% while the S&P 500 gained 0.17%. This severe underperformance reflects market skepticism about the Iridium deal and high valuation.
RKLB Technical Analysis
Rocket Lab's stock has exhibited a volatile but broadly upward trend over the past year, with a 1-year price change of +41.44%, significantly outperforming the S&P 500's +18.19% over the same period. However, the current price of $64.95 sits near the lower end of its 52-week range, at approximately 26% of the range (calculated as (64.95 - 37.57) / (151.00 - 37.57) = 24.3%), indicating a substantial pullback from the highs. This positioning suggests the stock is in a corrective phase after a strong rally, with the potential for value buying or further downside depending on market sentiment.
Beta
2.63
2.63x market volatility
Max Drawdown
-61.0%
Largest decline past year
52-Week Range
$38-$151
Price range past year
Annual Return
+71.6%
Cumulative gain past year
| Period | RKLB Return | S&P 500 |
|---|---|---|
| 1m | -9.3% | +2.8% |
| 3m | -28.3% | +4.2% |
| 6m | +4.6% | +11.3% |
| 1y | +71.6% | +21.5% |
| ytd | -0.4% | +12.7% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
RKLB Fundamental Analysis
Rocket Lab's revenue trajectory is robustly accelerating, with Q1 2026 revenue of $200.3 million, up 63.5% year-over-year, and sequential growth from $179.7 million in Q4 2025 and $155.1 million in Q3 2025. The growth is driven by both Launch Services and Space Systems, with product revenue of $127.5 million and service revenue of $72.9 million in the latest quarter. This strong momentum is supported by a record backlog, including a $266 million contract from the U.S. Space Force, and the Iridium acquisition, which is expected to further boost revenue. However, the company remains unprofitable, with a net loss of $45.0 million in Q1 2026, though the net loss margin improved to -22.5% from -29.5% in Q4 2025, indicating progress toward profitability.
Quarterly Revenue
$200348000.0B
2026-03
Revenue YoY Growth
+63.5%
YoY Comparison
Gross Margin
38.2%
Latest Quarter
Free Cash Flow
$-316301000.0B
Last 12 Months
Revenue & Net Income Trends (2 Years)
Revenue Breakdown
Open an Account, get $2 TSLA now!
Valuation Analysis: Is RKLB Overvalued?
Given Rocket Lab's negative net income, the price-to-sales (P/S) ratio is the most appropriate valuation metric, as earnings-based multiples are not meaningful. The trailing P/S ratio is 61.5x, while the forward P/S (based on estimated revenue of $2.64 billion) is approximately 14.0x, implying a significant expected revenue growth. This gap suggests the market is pricing in substantial future expansion, which is optimistic given the company's current unprofitable status. Compared to the aerospace & defense industry average P/S of around 2.5x, Rocket Lab trades at a massive premium, reflecting its high-growth potential but also leaving little room for error. Historically, the P/S ratio has ranged from 21x to 222x over the past two years, with the current 61.5x near the middle of that range, indicating that while the stock is not at its most extreme valuation, it remains richly priced relative to its fundamentals.
PE
-188.5x
Latest Quarter
vs. Historical
N/A
5-Year PE Range 17x~59x
vs. Industry Avg
N/A
Industry PE ~N/A*
EV/EBITDA
-234.4x
Enterprise Value Multiple
Investment Risk Disclosure
Worst-Case Scenario: The most damaging scenario would involve a failed Iridium integration, leading to cost overruns, revenue shortfalls, and a loss of investor confidence. This could trigger a downward spiral: the stock, already down 58% from its high, could fall to its 52-week low of $37.57, implying a -42% loss from the current price of $64.95. Analysts' low target of $77.00 is 18.6% above current, but in a worst case, the stock could overshoot to the downside if the company misses revenue estimates or faces a liquidity crunch. The max drawdown of -60.99% suggests that a drop to $25-30 is not impossible in a severe scenario, though the 52-week low is a more realistic reference point.